Profile
Corporate information
Official name
S-biomedic NV
Investment activity status
Active investor
Overview
The Belgian biotech startup S-Biomedic uses a proprietary technology to source and combine beneficial bacteria directly from healthy human skin to develop break-through treatments for skin conditions. This ensures that beneficial microbes colonize the skin in the most efficient way to rebalance the microbiome and ensure a long term and sustainable treatment.
Funding
Funding rounds
(2018) Change in valuation: unknown
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Beiersdorf | Initial investment. Round participant. | ||
|
Verve Capital Partners AG | Switzerland | Initial investment. Round participant. |
Change in valuation: unknown
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
DSM Venturing | The corporate venturing arm of Royal DSM NV. | Netherlands | Initial investment. Round participant. |
Change in valuation: unknown
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
Johnson & Johnson Innovation LLC | Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. | United States | Initial investment. Round participant. |
Change in valuation: unknown
| Investor | Profile | Country | Notes | |
|---|---|---|---|---|
|
|
CG Health Ventures | Initial investment. Round participant. |
Cap Table
Current and past shareholders
| Investor | Contacts | Round | |
|---|---|---|---|
|
|
Beiersdorf |
Series A | |
|
|
CG Health Ventures |
N/A | |
|
|
DSM Venturing The corporate venturing arm of Royal DSM NV. |
+31 (46) 476-3638 |
N/A |
|
|
Johnson & Johnson Innovation LLC Accelerator of early-stage innovation worldwide that forms collaborations between entrepreneurs and Johnson & Johnson’s global healthcare businesses. |
+1 (732) 524-3218 |
N/A |
|
|
Verve Capital Partners AG |
Series A |